According to Immuneering's latest financial reports the company's current EPS (TTM) is -$2.70. In 2022 the company made an earnings per share (EPS) of -$2.68 a decrease over its 2021 EPS that were of -$2.36.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.61 | -2.79% |
2022 | -$2.68 | 13.92% |
2021 | -$2.36 | 33.64% |
2020 | -$1.76 |